131 related articles for article (PubMed ID: 8783996)
1. Adverse effects of crystalloid cardioplegia and slow cooling for protection of immature rat hearts.
Karck M; Schnabel PA; Kilkowski A; Schulte S; Haverich A
Ann Thorac Surg; 1996 Sep; 62(3):702-9. PubMed ID: 8783996
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
Baker JE; Boerboom LE; Olinger GN
J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
[TBL] [Abstract][Full Text] [Related]
3. Cardioplegia-induced damage to ischemic immature myocardium is independent of oxygen availability.
Baker JE; Boerboom LE; Olinger GN
Ann Thorac Surg; 1990 Dec; 50(6):934-9. PubMed ID: 2241386
[TBL] [Abstract][Full Text] [Related]
4. The immature and the mature myocardium. Responses to multidose crystalloid cardioplegia.
Magovern JA; Pae WE; Miller CA; Waldhausen JA
J Thorac Cardiovasc Surg; 1988 Apr; 95(4):618-24. PubMed ID: 3352295
[TBL] [Abstract][Full Text] [Related]
5. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
[TBL] [Abstract][Full Text] [Related]
6. Calcium content of St. Thomas' II cardioplegic solution damages ischemic immature myocardium.
Baker EJ; Olinger GN; Baker JE
Ann Thorac Surg; 1991 Oct; 52(4):993-9. PubMed ID: 1929665
[TBL] [Abstract][Full Text] [Related]
7. Transient hypocalcemic reperfusion does not improve postischemic recovery in the rat heart after preservation with St. Thomas' Hospital cardioplegic solution.
Chambers DJ; Harvey DM; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):344-56. PubMed ID: 1495296
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
Greenfield DT; Greenfield LJ; Hess ML
J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
[TBL] [Abstract][Full Text] [Related]
9. Protection of the immature myocardium. An experimental evaluation of topical cooling, single-dose, and multiple-dose administration of St. Thomas' Hospital cardioplegic solution.
Magovern JA; Pae WE; Waldhausen JA
J Thorac Cardiovasc Surg; 1988 Sep; 96(3):408-13. PubMed ID: 3411985
[TBL] [Abstract][Full Text] [Related]
10. Adverse effect of prearrest hypothermia in immature hearts: rate versus duration of cooling.
Hosseinzadeh T; Tchervenkov CI; Quantz M; Chiu RC
Ann Thorac Surg; 1992 Mar; 53(3):464-71. PubMed ID: 1540065
[TBL] [Abstract][Full Text] [Related]
11. Effect of sodium aspartate on the recovery of the rat heart from long-term hypothermic storage.
Galiñanes M; Chambers DJ; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Mar; 103(3):521-31. PubMed ID: 1545551
[TBL] [Abstract][Full Text] [Related]
12. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
Kempsford RD; Hearse DJ
J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
[TBL] [Abstract][Full Text] [Related]
13. Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia.
Robinson LA; Harwood DL
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):314-25. PubMed ID: 1992242
[TBL] [Abstract][Full Text] [Related]
14. Functional recovery of hearts after cardioplegia and storage in University of Wisconsin and in St. Thomas' Hospital solutions.
Choong YS; Gavin JB
J Heart Lung Transplant; 1991; 10(4):537-46. PubMed ID: 1911796
[TBL] [Abstract][Full Text] [Related]
15. L-aspartate improves the functional recovery of explanted hearts stored in St. Thomas' Hospital cardioplegic solution at 4 degrees C.
Choong YS; Gavin JB
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):510-7. PubMed ID: 2308369
[TBL] [Abstract][Full Text] [Related]
16. Protection of the hypertrophied myocardium by crystalloid cardioplegia.
Munfakh NA; Steinberg JB; Titus JS; Denenberg AG; O'Keefe DD; Daggett WM; Geffin GA
J Surg Res; 1991 Dec; 51(6):447-56. PubMed ID: 1834890
[TBL] [Abstract][Full Text] [Related]
17. Myocardial protection in the neonatal heart. A comparison of topical hypothermia and crystalloid and blood cardioplegic solutions.
Corno AF; Bethencourt DM; Laks H; Haas GS; Bhuta S; Davtyan HG; Flynn WM; Drinkwater DC; Laidig C; Chang P
J Thorac Cardiovasc Surg; 1987 Feb; 93(2):163-72. PubMed ID: 3807393
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three cardioplegic solutions during hypothermic ischemic arrest in neonatal blood-perfused rabbit hearts.
Konishi T; Apstein CS
J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1132-7. PubMed ID: 2586132
[TBL] [Abstract][Full Text] [Related]
19. Enhanced myocardial protection with high-energy phosphates in St. Thomas' Hospital cardioplegic solution. Synergism of adenosine triphosphate and creatine phosphate.
Robinson LA; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1987 Mar; 93(3):415-27. PubMed ID: 3821150
[TBL] [Abstract][Full Text] [Related]
20. Protection of the hypertrophied human heart by adjusting regional myocardial temperature to a safe level.
Scheld HH; Görlach G; Mulch J; Podzuweit T; Höge R; Hehrlein FW; Schaper W
Thorac Cardiovasc Surg; 1985 Aug; 33(4):235-8. PubMed ID: 2413576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
